A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).

Clinical trial NCT01305252 · COMPLETED

Trial details

NCT number: NCT01305252
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension, Pulmonary

Start date: 2010-07-01
Primary completion: 2014-09-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.